Advagraf 0.5 mg

ADVAGRAF 0.5 MG capsules are an extended-release formulation of tacrolimus, used to prevent organ rejection post-transplant. This immunosuppressant helps maintain transplant success by reducing immune responses.

ADVAGRAF 0.5 MG is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. Tacrolimus works by suppressing the immune system, allowing the body to accept the transplanted organ. This medication is often prescribed as part of a broader immunosuppressive regimen to ensure long-term transplant success.

Common effects of ADVAGRAF 0.5 MG may include headaches, tremors, and gastrointestinal discomfort. Some users might experience changes in blood pressure or blood sugar levels. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

ADVAGRAF 0.5 MG should be handled with care, as it is an immunosuppressant. Patients should avoid activities that increase the risk of infection and follow a balanced diet to support overall health. Regular blood tests may be required to monitor kidney function and drug levels in the blood.

ADVAGRAF 0.5 MG may interact with various medications, including certain antibiotics, antifungals, and antivirals. Grapefruit and grapefruit juice should be avoided, as they can affect the metabolism of tacrolimus. Always inform your healthcare provider about all medications and supplements you are taking.